PL3500287T3 - Kompozycja zawierająca samoorganizujące się peptydy do stosowania do leczenia zapalenia przyzębia i/lub zapalenia tkanek okołowszczepowych - Google Patents

Kompozycja zawierająca samoorganizujące się peptydy do stosowania do leczenia zapalenia przyzębia i/lub zapalenia tkanek okołowszczepowych

Info

Publication number
PL3500287T3
PL3500287T3 PL17755151.2T PL17755151T PL3500287T3 PL 3500287 T3 PL3500287 T3 PL 3500287T3 PL 17755151 T PL17755151 T PL 17755151T PL 3500287 T3 PL3500287 T3 PL 3500287T3
Authority
PL
Poland
Prior art keywords
periodongitis
treatment
composition containing
containing self
organizing
Prior art date
Application number
PL17755151.2T
Other languages
English (en)
Inventor
Michael Hug
Dominikus Amadeus Lysek
Franziska Koch
Ronald Jung
Stephanie Mathes
Nina Meyer
Christoph Hämmerle
Frank Bröseler
Uwe Pieles
Original Assignee
Credentis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP16184309.9A external-priority patent/EP3284477A1/en
Application filed by Credentis Ag filed Critical Credentis Ag
Publication of PL3500287T3 publication Critical patent/PL3500287T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/12—Materials or treatment for tissue regeneration for dental implants or prostheses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Birds (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
PL17755151.2T 2016-08-16 2017-08-16 Kompozycja zawierająca samoorganizujące się peptydy do stosowania do leczenia zapalenia przyzębia i/lub zapalenia tkanek okołowszczepowych PL3500287T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16184309.9A EP3284477A1 (en) 2016-08-16 2016-08-16 Composition comprising self-assembling peptides for use in treatment of gingivitis, periodontitis and/or peri-implantitis
EP16200655 2016-11-25
PCT/EP2017/070758 WO2018033570A1 (en) 2016-08-16 2017-08-16 Composition comprising self-assembling peptides for use in treatment of gingivitis, periodontitis and/or peri-implantitis

Publications (1)

Publication Number Publication Date
PL3500287T3 true PL3500287T3 (pl) 2022-08-22

Family

ID=59683561

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17755151.2T PL3500287T3 (pl) 2016-08-16 2017-08-16 Kompozycja zawierająca samoorganizujące się peptydy do stosowania do leczenia zapalenia przyzębia i/lub zapalenia tkanek okołowszczepowych

Country Status (10)

Country Link
US (1) US12280087B2 (pl)
EP (1) EP3500287B1 (pl)
JP (1) JP7094023B2 (pl)
CN (1) CN109715193A (pl)
CA (1) CA3026021A1 (pl)
DK (1) DK3500287T3 (pl)
ES (1) ES2926140T3 (pl)
PL (1) PL3500287T3 (pl)
SG (1) SG11201810726QA (pl)
WO (1) WO2018033570A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3820810A4 (en) * 2018-07-12 2022-06-08 Ramot at Tel-Aviv University Ltd. SELF-ORGANIZED NANOSTRUCTURES AND COMPOSITES FOR DENTAL APPLICATIONS WITH THEM
EP3763348A1 (en) * 2019-07-10 2021-01-13 Credentis AG Self-assembling peptides in the prevention and treatment of cavitated carious lesions
EP3831360A1 (en) * 2019-12-04 2021-06-09 Credentis AG Personal dental care product for preventing demineralisation
WO2021111172A1 (en) * 2019-12-04 2021-06-10 Datum Dental Ltd. A collagen-hydroxyapatite device for non-surgical periodontal treatment
WO2021191903A1 (en) * 2020-03-26 2021-09-30 Bone Sci. Bio Ltd. Pharmaceutical compositions comprising amphiphilic peptides and methods of use thereof
US11154470B1 (en) 2020-07-31 2021-10-26 vVardis AG Anti-inflammatory and senolytic dental care product with tooth whitening characteristics
EP3984517A1 (en) * 2020-10-19 2022-04-20 Credentis AG Accelerating tooth remineralisation and bone regeneration with self-assembling peptides and amorphous calcium phosphate
KR20230122899A (ko) * 2022-02-15 2023-08-22 주식회사 나이벡 항균, 항염증 또는 조직재생능을 구비하는 펩타이드 및 이의 용도
CN117339017A (zh) * 2023-10-08 2024-01-05 东南大学附属中大医院 一种促进损伤肌腱再生修复的功能性双多肽水凝胶
CN118846053B (zh) * 2024-08-15 2024-11-22 温州医科大学附属口腔医院 兼具湿性黏附、光动抗菌和原位促进再矿化功能的Ce6@PDNs-SAP的制备及应用
CN120168402A (zh) * 2025-05-23 2025-06-20 皖南医学院第一附属医院（皖南医学院弋矶山医院） 用于牙周恢复的寡肽凝胶载体结构及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2994642A (en) * 1954-10-16 1961-08-01 Bossard Francois Jean Sodium chloride toothpaste having a silica aerogel carrier
GB0117011D0 (en) * 2001-07-12 2001-09-05 Univ Leeds Peptide barrels
GB0216286D0 (en) 2002-07-15 2002-08-21 Univ Leeds Network
US9101687B2 (en) 2002-07-15 2015-08-11 University Of Leeds Beta sheet tapes ribbons in tissue engineering
US8586539B2 (en) 2002-07-15 2013-11-19 University Of Leeds Beta sheet tapes ribbons in tissue engineering
JP4982841B2 (ja) 2005-10-12 2012-07-25 国立大学法人名古屋大学 再生医療骨組成物
US8741833B2 (en) * 2010-07-16 2014-06-03 Massachusetts Institute Of Technology Self-assembling peptides incorporating modifications and methods of use thereof
JP5906252B2 (ja) * 2010-12-20 2016-04-20 ステムニオン，インコーポレイテッド 歯科疾患、障害、および損傷の治療方法
EP2698162A1 (en) * 2012-08-15 2014-02-19 Credentis AG Method for producing a composition for treating a tooth lesion
EP2950777B1 (en) * 2013-01-30 2021-06-23 Straumann Holding AG Periodontal disease treatment
GB201306338D0 (en) * 2013-04-08 2013-05-22 Univ Leeds Novel proteoglycans
JP6649251B2 (ja) 2013-09-25 2020-02-19 クレデンティス・アクチェンゲゼルシャフトＣｒｅｄｅｎｔｉｓ ＡＧ 歯を白くするためのデンタルケア製品
EP2853256A1 (en) 2013-09-25 2015-04-01 Credentis AG Dental care product for tooth whitening
EP3157453A4 (en) * 2014-06-20 2018-01-24 3-D Matrix, Ltd Materials and methods for filling dental bone voids

Also Published As

Publication number Publication date
CA3026021A1 (en) 2018-02-22
CN109715193A (zh) 2019-05-03
JP7094023B2 (ja) 2022-07-01
EP3500287A1 (en) 2019-06-26
JP2019528274A (ja) 2019-10-10
WO2018033570A1 (en) 2018-02-22
DK3500287T3 (da) 2022-07-25
ES2926140T3 (es) 2022-10-24
US20190247540A1 (en) 2019-08-15
US12280087B2 (en) 2025-04-22
SG11201810726QA (en) 2019-02-27
EP3500287B1 (en) 2022-04-27

Similar Documents

Publication Publication Date Title
PL3500287T3 (pl) Kompozycja zawierająca samoorganizujące się peptydy do stosowania do leczenia zapalenia przyzębia i/lub zapalenia tkanek okołowszczepowych
EP3600082A4 (en) SURGICAL STAPLE AND STAPLE APPLICATOR
EP3597148C0 (en) IMPLANT FOR RETRACTION AND/OR SUPPORT OF PERIURETHRAL TISSUE
DK3504187T3 (da) Anvendelse af pridopidin til behandling af funktionel tilbagegang
EP3784260A4 (en) Compositions for the treatment of skin conditions
EP3603636A4 (en) COMPOSITION TARGETING S1PR4 TO PREVENT OR TREAT NON-ALCOHOLIC STEATOHEPATITIS
PL3381451T3 (pl) Kompozycja farmaceutyczna stosowana do redukcji zlokalizowanej tkanki tłuszczowej i zastosowanie kompozycji farmaceutycznej
EP3673899C0 (en) NASAL POWDER FORMULATION FOR THE TREATMENT OF HYPOGLYCEMIA
EP3790563A4 (en) Compositions for the treatment of skin conditions
PL3478719T3 (pl) Stosowanie przeciwciał przeciw sklerostynie w leczeniu wrodzonej łamliwości kości
DK3191103T3 (da) Sammensætninger og fremgangsmåder til behandling af præcancerøse hudlæsioner
EP3398437A4 (en) PESTICIDE COMPOSITION CONTAINING METCONAZOLE FOR PREVENTING AND TREATING FUSARIOSIS OF PPE AND ITS APPLICATION
DK3310190T3 (da) Sammensætning til behandling af kød og anvendelse af denne
EP3569238A4 (en) COMPOSITION FOR TREATING NEWBORN EHI
IL262508A (en) Methods and compositions for the treatment of degenerate bone
PL3732294T3 (pl) Tymohydrochinon do stosowania w leczeniu hiperglikemii
EP3677265C0 (en) COMPOSITION FOR PREVENTING OR TREATMENT OF SLEEP DISORDERS
EP3719032A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF HAIR LOSS
IL289371A (en) Methylthioninium for use in the treatment of synaptopathies
EP3773539A4 (en) COMPOSITIONS FOR THE TREATMENT OF THE SKIN
FR3035584B1 (fr) Materiel d'osteosynthese vertebrale
EP3683303A4 (en) MEGAMONAS FUNIFORMIS AND ITS APPLICATIONS
EP3565518C0 (en) SOLID ANHYDROUS COMPOSITION FOR THE CARE AND/OR MAKE-UP OF KERATIN MATERIALS
EP3612133A4 (en) Implantable scaffolds for treatment of sinusitis
FR3035318B1 (fr) Materiel d'osteosynthese vertebrale